Status:
UNKNOWN
Ultra-low Dose Oral Ketamine for Chronic Pain in the Primary Care Setting
Lead Sponsor:
University of Washington
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This project is a pilot study to evaluate the analgesic and opioid-sparing effects of ketamine in an ultra-low dose oral formulation as a novel intervention for treatment of chronic non-cancer pain in...
Detailed Description
Chronic pain is a major national public health issue, affecting about 100 million adults in the United States. Opioid pain medications are commonly used for treatment of chronic pain, but their use is...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Routine use of an opioid medication for non-cancer pain for more than six months
- A current average daily dose of greater than or equal to 20 mg morphine or equivalent
- Current prescription of an as-needed opioid suitable for downward titration during the study period
- Ability to provide informed consent Ability to adhere to the study protocol
Exclusion
- Uncontrolled hypertension, cardiac arrhythmia or other known cardiac disease,
- elevated intracranial pressure,
- severe glaucoma,
- schizophrenia,
- diagnosed substance use disorder, or
- other unstable medical or psychiatric illness or pregnancy.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2015
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT02303847
Start Date
November 1 2014
End Date
June 1 2015
Last Update
May 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pioneer Family Practice
Lacey, Washington, United States, 98503